Onyx Pharmaceuticals, Inc. 2005 Equity Incentive Plan Option Agreement (Incentive Stock Option or Nonstatutory Stock Option)Option Agreement • March 5th, 2007 • Onyx Pharmaceuticals Inc • Biological products, (no disgnostic substances)
Pursuant to your Option Grant Notice (“Grant Notice”) and this Option Agreement, Onyx Pharmaceuticals, Inc. (the “Company”) has granted you an option under its 2005 Equity Incentive Plan (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. Defined terms not explicitly defined in this Option Agreement but defined in the Plan shall have the same definitions as in the Plan.
Onyx Pharmaceuticals, Inc. 2005 Equity Incentive Plan Non-Discretionary Grant Program For Directors Option Agreement (Nonstatutory Stock Option)Option Agreement • March 5th, 2007 • Onyx Pharmaceuticals Inc • Biological products, (no disgnostic substances)
Pursuant to your Option Grant Notice (“Grant Notice”) and this Option Agreement, Onyx Pharmaceuticals, Inc. (the “Company”) has granted you an option under the Non-Discretionary Grant Program of the 2005 Equity Incentive Plan (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. Defined terms not explicitly defined in this Option Agreement but defined in the Plan shall have the same definitions as in the Plan.
FIRST AMENDMENT TO SUBLEASESublease • March 5th, 2007 • Onyx Pharmaceuticals Inc • Biological products, (no disgnostic substances)
THIS FIRST AMENDMENT TO SUBLEASE (“First Amendment”) is entered into as of _Nov 3 , 2006, by and between ORACLE USA, INC., a Colorado corporation (“Sublandlord”) and ONYX PHARMACEUTICALS, INC., a Delaware corporation (“Subtenant”), with reference to the following facts.
